-
France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals
Sep 9, 2025, 16:22 PM -
Streamlining Cancer Treatment Pathways: Organizational Responses to Rising Chemotherapy Volumes
Sep 9, 2025, 16:22 PM -
ComboConnect—Bridging Access Gaps in Combination Therapies: An Italian Project in Collaboration With ISPOR Italy-Rome Chapter
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Health Economics: Opportunities and Challenges for the Future: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Feasibility Evaluation of Claims Database: Best Practices and Case Study for a Comparative Analysis of Robotic-Assisted Colorectal Surgery in Germany
Sep 9, 2025, 16:22 PM -
Antibody-Drug Conjugates in Colorectal Cancer: A Scoping Review of Current Evidence and Emerging Clinical Trends
Sep 9, 2025, 16:22 PM -
NMAs of Systemic Therapies for Advanced Biliary Tract Cancer: A Systematic Review and Critical Appraisal Using RoB NMA
Sep 9, 2025, 16:22 PM -
Psychometric Evaluation of the Immune Thrombocytopenic Purpura Patient Assessment Questionnaire Item-10 (Physical Fatigue) and Idiopathic Thrombocytopenic Purpura Bleeding Scale Using LUNA 3 Phase 3 Trial Data
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of Biosimilars in Europe: A Cost Analysis of Infliximab, Trastuzumab, and Rituximab
Sep 9, 2025, 16:22 PM -
Real-World Differences in Breast Cancer Management by Detection Method: A Czech National Analysis
Sep 9, 2025, 16:22 PM -
Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada
Sep 9, 2025, 16:22 PM -
Modeling Framework for Assessing Cost-Effectiveness of New Treatments in Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab for the First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC) That Expresses High Levels of PD-L1 in Türkiye
Sep 9, 2025, 16:22 PM -
NICE Technology Appraisal Submissions for Non-Small Cell Lung Cancer: Analysis and Insights
Sep 9, 2025, 16:22 PM -
Enhancing Palliative Care in Intensive Care Units (EPIC) Trial Design of the Health Economic Substudy
Sep 9, 2025, 16:22 PM -
Estimating the Broader Societal Impact of Ocrelizumab for Multiple Sclerosis (MS) in Latin America (LATAM) Using a Social Impact Approach
Sep 9, 2025, 16:22 PM -
Modeling What Matters: The Real-World Burden of Pregnancy-Related Complications in cTTP
Sep 9, 2025, 16:22 PM -
Real-World Evidence in Action: Assessing Drug-Drug Interactions to Drive Value-Based Decisions
Sep 9, 2025, 16:22 PM -
Digital Health Technologies Assessment Based on Patient-Reported Outcome Measures (PROMs): Virtual Reality (VR) in the Treatment of Specific Phobias
Sep 9, 2025, 16:22 PM
